PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 8521592

Pseudohyperphosphatemia.

A J Larner
View original source ↗Export metadata ↓

Abstract

OBJECTIVE: To review instances of spurious elevation of inorganic phosphate measurements due to interference with analytical methods. METHODS: SElective literature review. RESULTS: Depending on the method used to measure inorganic phosphate, several factors have been reported to produce spurious elevations, including paraproteinemia, hyperlipidemia, hemolysis, and hyperbilirubinemia. Of these, paraproteinemia is probably the commonest. CONCLUSION: Both clinical biochemists and clinicians should be aware of the phenomenon of pseudohyperphosphatemia. Clinically unexplained persistent hyperphosphatemia should initiate a search for potential causes of pseudohypophosphatemia, especially paraproteinemia.

Explore related subjects

Blood Chemical AnalysisFalse Positive ReactionsHumansPhosphatesJournal ArticleResearch Support, Non-U.S. Gov'tReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A J Larner. 1995. Pseudohyperphosphatemia.. https://doi.org/10.1016/0009-9120(95)00013-y

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1997

Quantitative capillary electrophoresis/ion spray tandem mass spectrometry determination of EDTA in human plasma and urine.

A quantitative method has been developed for the determination of EDTA in human plasma and urine. The samples are prepared with automated anion-exchange solid-phase extraction using 100 microL of human plasma. The extracts are analyzed by capillary electrophoresis/mass spectrometry using selected reaction monitoring in the negative ion mode. Large-volume injections (10% of the CE capillary volume) are used to improve the concentration level of detection via field-amplified sample injection. The first reported validation of a CE/MS/MS technique was carried out for this method. Using a 13C stable-label isotope for the internal standard, the lower level of detection and lower level of quantitation were determined to be 7.3 and 14.6 ng/mL EDTA in human plasma, respectively. The injection precision had a relative standard deviation (RSD) of 6.1%. The intra-assay precision was less than 15% RSD. The intra-assay accuracy was less than +/- 12% bias from the nominal concentration. The interassay precision was less than 18% RSD and the interassay accuracy was less than +/- 9% bias from the nominal concentration.

Blood Chemical Analysis↗